Novavax
NVAX
$14.00
Share price
-0.14%
Change (1 day)
109.90%
Change (1 year)
Categories
Earnings for Novavax (NVAX)
Earnings in 2023 (TTM): -$0.53 B
According to Novavax's latest financial reports the company's current earnings (TTM) are -$0.39 B. an increase over its 2022 earnings that were of -$0.64 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novavax from 2002 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.53 B | -16.59% |
| 2022 | -$0.64 B | -62.58% |
| 2021 | -$1.7 B | 320.54% |
| 2020 | -$0.41 B | 234.22% |
| 2019 | -$0.13 B | -30.17% |
| 2018 | -$0.18 B | 1.69% |
| 2017 | -$0.17 B | -36.44% |
| 2016 | -$0.27 B | 70.4% |
| 2015 | -$0.16 B | 89.27% |
| 2014 | -$82.79 M | 59.83% |
| 2013 | -$51.8 M | 81.9% |
| 2012 | -$28.48 M | 50.33% |
| 2011 | -$18.95 M | |
| 2009 | -$37.39 M | 8.8% |
| 2008 | -$34.36 M | 18.01% |
| 2007 | -$29.12 M | 18.33% |
| 2006 | -$24.61 M | 168.31% |
| 2005 | -$9.18 M | -62.51% |
| 2004 | -$24.47 M | 52.4% |
| 2003 | -$16.06 M | -28.21% |
| 2002 | -$22.36 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.82 B | -2,676.65% | 🇨🇭 Switzerland |
 Pfizer PFE | $0.89 B | -333.36% | 🇺🇸 USA |
 AstraZeneca AZN | $9.08 B | -2,481.05% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $6.88 B | -1,905.29% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $34.06 M | -108.93% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.16 B | -60.62% | 🇺🇸 USA |
 Agenus
AGEN | -$0.14 B | -63.50% | 🇺🇸 USA |
 NanoViricides NNVC | -$9.51 M | -97.51% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.21 B | -45.31% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.47 B | 21.71% | 🇺🇸 USA |